Abliva discovers and develops medicines for the treatment of mitochondrial disease. This rare and often very severe disease occurs when the cell’s energy provider, the mitochondria, do not function properly. The company has prioritized two projects. KL1333, a powerful regulator of the essential co-enzymes NAD⁺ and NADH, has entered late-stage development. NV354, an energy replacement therapy, has completed preclinical development. Abliva is based in Lund, Sweden.
| Website | http://www.abliva.com |
| Ticker | ABLI |
| Employees | 9 (3 on RocketReach) |
| Founded | 2000 |
| Address | 1 Scheeletorget, Lund, Skane 223 63, SE |
| Phone | +46 46 275 62 20 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
| Keywords | Mitochondrial Diseases, Rare Diseases, Severe Diseases, Drug Discovery, Pharmaceutical Research, Biopharmaceutical, Clinical Development, Drug Development, Cellular Energy, Genetic Diseases, Medical Research, Pharmaceutical, Biotechnology, Life Sciences, Therapeutics, Health |
| Competitors | AstraZeneca, GenSight Biologics, Orchard Therapeutics, Eton Pharmaceuticals, Inc, IMUNON, MedinCell, TIZIANA LIFE SCIENCES PLC, Otonomy, Inc, Cytokinetics, Soligenix, Inc. +43 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Abliva Ab employee's phone or email?
Abliva Ab Questions
Ellen Donnelly is the CEO of Abliva Ab.
3 people are employed at Abliva Ab.
Abliva Ab is based in Lund, Skane.
The NAICS codes for Abliva Ab are [325, 32].
The SIC codes for Abliva Ab are [283, 28].
Top Abliva Ab Employees
-
Ellen Donnelly
Chief Executive Officer at Abliva Ab
United States25 -
11
Related Companies
